Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Industry News

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

July 23, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

May 02, 2016

News Industry News

Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

February 02, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

News Industry News

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

October 16, 2015

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Industry News

FDA Clears Next-Generation Guide Wire for Cardiovascular Systems' Peripheral Orbital Atherectomy Systems

July 07, 2015

News Industry News

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

February 24, 2015

News Industry News

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

September 15, 2014

News Industry News

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

June 06, 2014

News Industry News

Tianjin & AstraZeneca Collaborate On Cardiovascular Disease

May 19, 2014

News Industry News

TROPONIN I RAPID DIAGNOSTIC TEST

May 15, 2014

News Industry News

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

May 08, 2014

News Industry News

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

May 23, 2013

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

Advertisement

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

FDA Clears Next-Generation Guide Wire for Cardiovascular Systems' Peripheral Orbital Atherectomy Systems

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

Tianjin & AstraZeneca Collaborate On Cardiovascular Disease

TROPONIN I RAPID DIAGNOSTIC TEST

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

Gore Reacts to RESPECT Trial Results

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content